FIELD: medicine. SUBSTANCE: method involves intramuscularly administering rheaferon before cycloferon being taken, at a dose of 3 mln of MU 3 times a week during 18-20 days. Cycloferon treatment course is to be prolonged to 7-9 weeks ones per 5 days at a dose of 600 mg. 2-4 courses of combined rheaferon and cycloferon therapy are carried out on the background of vitamins B group and hepatoprotector agents consumption. EFFECT: enhanced effectiveness of treatment; improved clinical, biochemical and virusological parameters. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SELECTION OF MEDICINAL PREPARATIONS FOR TREATMENT OF PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2002 |
|
RU2221243C1 |
| METHOD OF DETERMINING NARCOTIC INTOXICATION OF HUMAN ORGANISM | 2003 |
|
RU2256911C2 |
| METHOD FOR PREDICTING CLINICAL CHRONIC HEPATITIS COURSE ON THE DRUG INTOXICATION BACKGROUND | 2004 |
|
RU2267998C2 |
| METHOD OF TREATING PATIENTS WITH CHRONIC VIRAL HEPATITIS TYPE C, GENOTYPE 3a | 2009 |
|
RU2400229C1 |
| METHOD FOR TREATING THE CHRONIC VIRAL HEPATITIS C PATIENTS HAVING HEPATIC HEMOSIDEROSIS | 1999 |
|
RU2180599C2 |
| AGENT FOR TREATMENT OF PATIENTS WITH HEPATITIS AND FIBROSIS SYMPTOMS | 2000 |
|
RU2164802C1 |
| METHOD FOR TREATING THE PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AT APPLYING THE CRYOHEPARINOPRECIPITATION | 2000 |
|
RU2188012C2 |
| METHOD FOR TREATMENT OF LIVER DISEASE | 2004 |
|
RU2286773C2 |
| METHOD FOR INDIVIDUAL MATCHING MEDICINAL PREPARATIONS FOR TREATING PATIENTS WITH ETIOLOGICALLY DIFFERENT ACUTE AND CHRONIC VIRAL HEPATITIS | 2002 |
|
RU2222011C1 |
| METHOD FOR EVALUATING HEPATIC HEMODYNAMICS | 2002 |
|
RU2214158C1 |
